These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21345948)

  • 1. Unique spectrum of activity of prosimian TRIM5alpha against exogenous and endogenous retroviruses.
    Rahm N; Yap M; Snoeck J; Zoete V; Muñoz M; Radespiel U; Zimmermann E; Michielin O; Stoye JP; Ciuffi A; Telenti A
    J Virol; 2011 May; 85(9):4173-83. PubMed ID: 21345948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
    Stremlau M; Perron M; Welikala S; Sodroski J
    J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates.
    Song B; Gold B; O'Huigin C; Javanbakht H; Li X; Stremlau M; Winkler C; Dean M; Sodroski J
    J Virol; 2005 May; 79(10):6111-21. PubMed ID: 15857996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha.
    Perron MJ; Stremlau M; Sodroski J
    J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.
    Song B; Javanbakht H; Perron M; Park DH; Stremlau M; Sodroski J
    J Virol; 2005 Apr; 79(7):3930-7. PubMed ID: 15767395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.
    Ohkura S; Yap MW; Sheldon T; Stoye JP
    J Virol; 2006 Sep; 80(17):8554-65. PubMed ID: 16912305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
    Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
    Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
    J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
    Diaz-Griffero F; Perron M; McGee-Estrada K; Hanna R; Maillard PV; Trono D; Sodroski J
    Virology; 2008 Sep; 378(2):233-42. PubMed ID: 18586294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral activity of ancestral TRIM5alpha.
    Goldschmidt V; Ciuffi A; Ortiz M; Brawand D; Muñoz M; Kaessmann H; Telenti A
    J Virol; 2008 Mar; 82(5):2089-96. PubMed ID: 18077724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
    Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
    J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMO-interacting motifs of human TRIM5α are important for antiviral activity.
    Arriagada G; Muntean LN; Goff SP
    PLoS Pathog; 2011 Apr; 7(4):e1002019. PubMed ID: 21490953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
    Maillard PV; Reynard S; Serhan F; Turelli P; Trono D
    PLoS Pathog; 2007 Dec; 3(12):e200. PubMed ID: 18166079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
    Perron MJ; Stremlau M; Song B; Ulm W; Mulligan RC; Sodroski J
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11827-32. PubMed ID: 15280539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity.
    Perez-Caballero D; Hatziioannou T; Yang A; Cowan S; Bieniasz PD
    J Virol; 2005 Jul; 79(14):8969-78. PubMed ID: 15994791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a single amino acid in the variable region 2 of the Old World monkey TRIM5alpha SPRY (B30.2) domain on anti-human immunodeficiency virus type 2 activity.
    Kono K; Bozek K; Domingues FS; Shioda T; Nakayama EE
    Virology; 2009 May; 388(1):160-8. PubMed ID: 19342071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insight into HIV-1 capsid recognition by rhesus TRIM5α.
    Yang H; Ji X; Zhao G; Ning J; Zhao Q; Aiken C; Gronenborn AM; Zhang P; Xiong Y
    Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18372-7. PubMed ID: 23091002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.
    Yap MW; Nisole S; Stoye JP
    Curr Biol; 2005 Jan; 15(1):73-8. PubMed ID: 15649369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of Sylvilagus rabbit TRIM5α species-specific domain: how ancient endoviruses could have shaped the antiviral repertoire in Lagomorpha.
    de Matos AL; van der Loo W; Areal H; Lanning DK; Esteves PJ
    BMC Evol Biol; 2011 Oct; 11():294. PubMed ID: 21982459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.
    Ohmine S; Sakuma R; Sakuma T; Thatava T; Takeuchi H; Ikeda Y
    PLoS One; 2011 Jan; 6(1):e16121. PubMed ID: 21264255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.